Biotech

Retrotope Announces Phase I/II Clinical Trial Results of RT001 in Treatment of Friedreich''s Ataxia

LOS ALTOS, CA: First-in-Human Trial Achieves Safety, Tolerability, and PK Goals, With Early Signals of Efficacy ...

Io Therapeutics, Inc. Reports Data Demonstrating That the Company''s Candidate Treatment for Multiple Sclerosis, IRX4204, Promotes Repair of Damaged Myelin

SANTA ANA, CA: ...

Aldeyra Therapeutics Appoints Richard H. Douglas to Its Board of Directors

LEXINGTON, MA: ...

Bioz Launches Ambassador Program to Accelerate the Pace of Scientific Research and Drug Discovery

PALO ALTO, CA: New Software Startup Experiences Enormous Worldwide Adoption of Industry's First Search Engine Built for Life Science Experimentation ...

Crop Enhancement Secures $8.5M in Series B Funding to Help Farmers Sustainably Increase Crop Yield While Minimizing or Eliminating Pesticide Use

CAMBRIDGE, MA: MLS Capital Fund II and 1955 Capital Co-Led the Round, With Bandgap Ventures and Initial Investor Phoenix Venture Partners Rounding Out the Syndicate ...

Hemostemix Announces Results of Annual and Special Meeting

CALGARY, ALBERTA: ...

Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte''s IDO1 Enzyme Inhibitor Epacadostat

HALIFAX, NOVA SCOTIA: Trial is Evaluating Safety and Immunogenicity of Triple Combination Therapy in Patients With Recurrent Ovarian Cancer ...

Pharma-Bio Third-Quarter 2016 Update: $5.8 Billion Investment in Project Starts Reflects Good Health of the Industry, an Industrial Info News Alert

SUGAR LAND, TX: ...

Theravance Biopharma Announces New Employment Inducement Awards

DUBLIN, IRELAND: ...

Concerned Shareholders Thank Hemostemix Inc. Shareholders for Resounding Support for Much Needed Change to Board of Directors, Provides Progress Update and Clarifies Misleading Statements

CALGARY, ALBERTA: ...